Bits of technology from I.B.M.’s Watson are beginning to be used in actual products available to corporate clients. The cloud-based Strategic Intellectual Property Insight Platform “uses data mining, natural-language processing and analytics to pore through millions of patent filings and biomedical journals to look for chemical compounds used in drug discovery.” As a byproduct of this project, I.B.M. is contributing their research to the searchable NIH chemical database, which will ease access to information previously mired in paperwork.
Subscribe to our e-newsletterVIEW OUR CURRENT ISSUE >
Tagsbiofuels Intellectual Property health BIOTECH BIO EVENT Health Care BIO International Convention USPTO Benefits of biotech crops climate change Plant biotechnology GMOs agriculture healthcare biotechnology Food Sustainability biotech industry BIO global food crisis
- Most Popular
Latest Videohttps://youtube.com/devicesupport View All >